Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-053105

Chief Executive Officer acquired 10,000 shares (conversion)

  • Chief Executive Officer gave 10,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Gibson Christopher · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2023-10-16 Conversion : show line 1 in the form +10,000 852,747 D
2023-10-16 Gift : show line 2 in the form −10,000 842,747 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2023-10-16 Conversion : show line 3 in the form Class B Common Stock −10,000 $0.00 10,000 6,501,496 D
Loading xslF345X05/doc4.xml…